CHRISTINA MEDRANO: Open Payments
NPI 1770562704 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 29 payments from 6 companies in 2025. Trend: 2023 $246 · 2024 $338 · 2025 $807
Food & beverage: $807
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $242 |
| ABBVIE INC. | 12 | $165 |
| Otsuka America Pharmaceutical, Inc. | 2 | $135 |
| Alkermes, Inc. | 2 | $127 |
| Teva Pharmaceuticals USA, Inc. | 2 | $122 |
| Tris Pharma Inc | 1 | $16 |
Products named: COBENFY, VRAYLAR, ABILIFY MAINTENA, UZEDY, LYBALVI, ARISTADA, ABILIFY ASIMTUFII, Dyanavel XR.
Industry payments across FL — which companies pay providers there.
